Agonists and Antagonists Acting at P2X7 Receptor

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|4|16|1707-1717

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.4, Iss.16, 2004-12, pp. : 1707-1717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent progress in the discovery of antagonists acting at P2X7 receptor

By Romagnoli Romeo   Baraldi Pier Giovanni   Di Virgilio Francesco  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 271-287

Informa Healthcare

Access to resources Recommend Favorite

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases

By Arulkumaran Nishkantha   Unwin Robert J   Tam Frederick WK  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 897-915

Informa Healthcare

Access to resources Recommend Favorite

Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists

By  

Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-03 ,pp. : 915-928

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential

By  

Current Medicinal Chemistry, Vol. 22, Iss. 6, 2015-02 ,pp. : 713-729

Bentham Science Publishers

Access to resources Recommend Favorite

Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma: A Pragmatic Trial

By Wilson Edward C.F.  

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 597-608

Adis International

Access to resources Recommend Favorite